BRIEF published on 11/18/2024 at 08:05, 3 days 4 hours ago OTAQ Announces Board Change with Director Resignation Technology Cost Reduction Aquaculture Board Resignation OTAQ
PRESS RELEASE published on 11/18/2024 at 08:00, 3 days 4 hours ago Board Change OTAQ plc announces the resignation of Non-Executive Director, Giles Clifford, as a cost reduction measure in the company Resignation OTAQ Plc Cost Reduction Non-Executive Director Giles Clifford
BRIEF published on 11/13/2024 at 08:05, 8 days 4 hours ago OTAQ Plc Reports Delays in Order Conversion Impacting FY24 Revenue OTAQ Plc Restructuring Aquaculture Order Delays Offshore Division
PRESS RELEASE published on 11/13/2024 at 08:00, 8 days 4 hours ago Trading Update OTAQ plc announces trading update for FY24, highlighting delays in order conversion impacting revenue forecasts. Company restructuring in progress for future prospects OTAQ Plc Trading Update Company Restructuring Revenue Forecasts Order Conversion
BRIEF published on 11/01/2024 at 08:05, 20 days 4 hours ago OTAQ Plc Announces Total Voting Rights Shareholders Ordinary Shares OTAQ Plc Total Voting Rights FCA Compliance
PRESS RELEASE published on 11/01/2024 at 08:00, 20 days 4 hours ago Total Voting Rights OTAQ plc announces total voting rights of 128,575,044 ordinary shares of 1 penny each. Compliance with FCA's Disclosure Guidance and Transparency Rules. Focus on aquaculture and offshore markets OTAQ Plc Total Voting Rights Offshore Markets FCA Aquaculture
BRIEF published on 10/31/2024 at 08:05, 21 days 4 hours ago OTAQ Plc Announces Board Changes Amid Cost-Cutting Measures OTAQ Plc Aquaculture Technology Board Changes Offshore Markets Cost-cutting
PRESS RELEASE published on 10/31/2024 at 08:00, 21 days 4 hours ago Board Changes OTAQ announces board changes as Harald Rotsch steps down and Sarah Stoten resigns to support cost-cutting measures. Company aims for long-term success and suitable governance Board Changes Cost-cutting Measures OTAQ Harald Rotsch Sarah Stoten
BRIEF published on 10/21/2024 at 17:42, 30 days 18 hours ago OTAQ Announces Share Incentive Plan Details and Voting Rights Update Voting Rights Share Incentive Plan Shareholding OTAQ Philip Newby
PRESS RELEASE published on 10/21/2024 at 17:37, 30 days 19 hours ago SIP Purchase, PDMR and Total Voting Rights OTAQ plc announces SIP Purchase, PDMR shareholding, and Total Voting Rights updates. The Company issued new Ordinary Shares under the Share Incentive Plan. Total Ordinary Shares post-admission: 128,575,044 OTAQ Plc SIP Purchase Share Incentive Plan Total Voting Rights PDMR Shareholding
Published on 11/21/2024 at 12:00, 38 minutes ago Alset AI Announces Full Repayment of $3.7 Million Secured Loan with Interest from Portfolio Company, Significantly Strengthening Balance Sheet
Published on 11/21/2024 at 12:00, 38 minutes ago Battery X Metals Commences Strategic Initiatives to Strengthen Balance Sheet
Published on 11/21/2024 at 11:30, 1 hour 8 minutes ago FireFox Trenching Returns More High-Grade Gold at the Mustajärvi Gold Project in Lapland, Finland
Published on 11/21/2024 at 10:03, 2 hours 35 minutes ago Pixotope Launches Revolutionary AI-Powered Graphics Integration Tool for Broadcast Industry
Published on 11/21/2024 at 10:00, 2 hours 38 minutes ago BluSky Carbon JV Entity BluMountain Enters into JV Partnership in Southeastern USA
Published on 11/21/2024 at 12:15, 23 minutes ago Hardman & Co Investor Forum Research on Shield Therapeutics (STX): Proactive cash management to cashflow-breakeven
Published on 11/21/2024 at 11:30, 1 hour 8 minutes ago APONTIS PHARMA AG: Condition of Minimum Acceptance in Zentiva’s Voluntary Public Purchase Offer Waived
Published on 11/21/2024 at 11:00, 1 hour 38 minutes ago First Patient Treated in Phase I/II Trial in Acute Myeloid and Acute Lymphoblastic Leukemia with Lu177-PentixaTher, Expanding the Evidence Base for Targeted Radiotherapy Approach
Published on 11/21/2024 at 06:58, 5 hours 40 minutes ago Net Asset Value per share increases with 9.4% in six months to EUR 55.6 thanks to continued strong growth performance of the portfolio
Published on 11/20/2024 at 19:20, 17 hours 18 minutes ago Peugeot Invest Board of Directors to evolve following the May 2025 Annual General Meeting
Published on 11/20/2024 at 17:45, 18 hours 53 minutes ago MEDESIS PHARMA HAS COMPLETED ITS CLINICAL STUDY FOR THE TREATMENT OF ALZHEIMER'S DISEASE WITH NANOLITHIUM
Published on 11/20/2024 at 17:45, 18 hours 53 minutes ago Disclosure of Share Capital and Voting Rights Outstanding as of October 31, 2024
Published on 11/20/2024 at 07:45, 1 day 4 hours ago Gimv sells to Fremman Capital a majority stake in outpatient rehabilitation specialist rehaneo
